Please assess the completion status of the following clinical trial:

Trial Title: Study of Efficacy and Safety of Ginger Extract Compared With Loratadine for Treatment of Allergic Rhinitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients have moderate allergic rhinitis (itching and nasal obstruction, watery nasal discharge, sneezing and congestion )with a minimum total nasal symptom score 7 point~2. These patients do not have the respiratory disease such as tuberculosis, nasal polyps.~3. These patients do not have the history of disease: heart disease, kidney disease, liver disease, epilepsy, high blood pressure and severe asthma.~4. These patients are not pregnant or breastfeeding.~5. These patients have normal BMI and vital signs.~Exclusion Criteria:~1. Those who have taken anti-coagulant and anti-platelet aggregation medications.~2. Those who get serious side effects from Loratadine and ginger allergy.~3. Communication problems especially listening and interview.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Ginger extract (Type: EXPERIMENTAL): Drug
- Loratadine (Type: ACTIVE_COMPARATOR): Drug

Based on this trial design, predict the completion outcome and termination type (if applicable).